OptimizeRx Corporation
OPRX
Positions held
Your positionsOPRX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $157.85M | Enterprise value | $153.23M | Trailing P/E | 34.92 | Forward P/E | 8.03 |
| PEG | 1.61 | Price / book | 1.20 | Beta | 1.26 | Dividend yield | 0.00% |
| Revenue growth | -29.8% | Earnings growth | — | Gross margin | 73.2% | Operating margin | -0.4% |
| Profit margin | 4.7% | ROE | 3.7% | ROA | 4.2% | Debt / equity | 0.15 |
| Current ratio | 5.58 | Free cash flow | $15.76M | Analyst recommendation | strong_buy | Mean target | $12.60 |
| 52w high | $22.25 | 52w low | $4.54 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $20.5M | $19.8M | $32.2M | $26.1M | $29.2M | — |
| Op margin | -0.4% | 2.0% | 27.7% | 7.9% | 11.0% | — |
| Net income | -$0.7M | -$0.5M | $5.0M | $0.8M | $1.5M | — |
| Gross margin | 76.5% | 75.2% | 74.8% | 67.2% | 63.8% | — |
| Gross profit | $15.7M | $14.9M | $24.1M | $17.5M | $18.6M | — |
| Operating income | -$0.1M | $0.4M | $8.9M | $2.0M | $3.2M | — |
- Revenue +3% vs prior quarter ($21M vs $20M).
- Gross margin 76.5% (was 75.2% prior quarter).
- Operating margin compressed to -0.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $109M | $92.1M | $71.5M | $62.5M | — |
| Op margin | 11.0% | -6.7% | -24.5% | -19.7% | — |
| Net income | $5.1M | -$20.1M | -$17.6M | -$11.4M | — |
| Gross margin | 67.3% | 64.5% | 60.0% | 62.4% | — |
| Gross profit | $73.6M | $59.4M | $42.9M | $39.0M | — |
| Operating income | $12.1M | -$6.2M | -$17.5M | -$12.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · What Trade Desk (TTD)'s Healthcare Inventory Integration With OptimizeRx Means For Shareholders
2026-09-29 · B. Riley Raises Price Target on OptimizeRx to $11 From $10, Keeps Buy Rating
2026-09-23 · Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
2026-09-22 · OptimizeRx Partners With The Trade Desk To Widen Its Healthcare Ad Network
2026-09-22 · OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
2026-09-14 · OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
2026-09-08 · OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
2026-09-02 · OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
2026-08-19 · OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript
2026-08-13 · OptimizeRx Corporation Q2 2026 Earnings Call Summary
2026-08-13 · OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
2026-08-13 · OptimizeRx Q2 Earnings Call Highlights
Price (daily)
Full chart · RSI · MACD · patterns